The club drug ketamine may treat depression—but the risks could be big
by Mandy Oaklander
Mar 11, 2017
3 minutes
FOR DOCTORS AND THE PEOPLE they care for, depression can be a vexing condition. It’s common—about 16% of American adults will be clinically depressed at some point in their lives—and yet about a third of those cases won’t respond to the standard treatments of antidepressants and psychotherapy. Stubborn depression can have dire long-term effects on people’s health and well-being: those with treatment-resistant depression tend to die nine years earlier, on average, than those whose
You’re reading a preview, subscribe to read more.
Start your free 30 days